Research Paper Volume 13, Issue 12 pp 16425—16444

Selected using bioinformatics and molecular docking analyses, PHA-793887 is effective against osteosarcoma

Anti-osteosarcoma effects of PHA-793887 targeting CDK1. (A) Results of western blot. (B) Relative expression of CDK1 (%Control) (C) CDK1 expression in MG63 cells.

Figure 6. Anti-osteosarcoma effects of PHA-793887 targeting CDK1. (A) Results of western blot. (B) Relative expression of CDK1 (%Control) (C) CDK1 expression in MG63 cells.